Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a
Tag: Difei Yang
Selecta Biosciences (SELB) Receives a Buy from Mizuho Securities
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Selecta Biosciences (SELB – Research
Mizuho Securities Sticks to Their Buy Rating for Aerie Pharma (AERI)
Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a
Xeris Pharmaceuticals (XERS) Receives a Buy from Mizuho Securities
Mizuho Securities analyst Difei Yang maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) today and set a
Mizuho Securities Thinks Xeris Pharmaceuticals’ Stock is Going to Recover
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research
Aerie Pharma (AERI) Received its Third Buy in a Row
After Needham and H.C. Wainwright gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy,
Mizuho Securities Thinks Xeris Pharmaceuticals’ Stock is Going to Recover
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research